HK Stock MarketDetailed Quotes
01515 CR MEDICAL
- 4.130
- 0.0000.00%
Market Closed Nov 12 16:08 CST
5.36BMarket Cap16.65P/E (TTM)
4.360High4.120Low10.61MVolume4.130Open4.130Pre Close45.08MTurnover0.82%Turnover Ratio18.86P/E (Static)1.30BShares5.01052wk High0.79P/B5.36BFloat Cap3.00552wk Low0.12Dividend TTM1.30BShs Float16.271Historical High0.066Dividend LFY5.81%Amplitude2.584Historical Low4.248Avg Price500Lot Size2.93%Div YieldTTM1.60%Div Yield LFY
CR MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.69%4.98B | 27.92%10.11B | 59.52%5.11B | 77.66%7.9B | 80.91%3.21B | 61.69%4.45B | 95.29%1.77B | 30.03%2.75B | -5.96%907.41M | 2.71%2.12B |
| Operating income | -2.69%4.98B | 27.92%10.11B | 59.52%5.11B | 77.66%7.9B | 80.91%3.21B | 61.69%4.45B | 95.29%1.77B | 30.03%2.75B | -5.96%907.41M | 2.71%2.12B |
| Cost of sales | 2.11%-3.94B | -24.35%-8.2B | -54.77%-4.02B | -87.69%-6.6B | -88.78%-2.6B | -66.21%-3.51B | -108.06%-1.38B | -56.25%-2.11B | -6.90%-662.09M | -3.86%-1.35B |
| Operating expenses | 2.11%-3.94B | -24.35%-8.2B | -54.77%-4.02B | -87.69%-6.6B | -88.78%-2.6B | -66.21%-3.51B | -108.06%-1.38B | -56.25%-2.11B | -6.90%-662.09M | -3.86%-1.35B |
| Gross profit | -4.86%1.04B | 45.95%1.91B | 79.91%1.09B | 39.88%1.31B | 53.45%605.46M | 46.67%933.56M | 60.84%394.57M | -16.50%636.51M | -29.01%245.32M | 0.74%762.29M |
| Selling expenses | 53.81%-2.44M | 86.03%-2.73M | 39.88%-5.28M | -16.39%-19.53M | -7.78%-8.78M | -15.06%-16.78M | -30.03%-8.15M | 9.61%-14.59M | 10.06%-6.26M | 18.87%-16.14M |
| Administrative expenses | -5.26%-471.58M | -20.05%-970.77M | -43.40%-448.03M | -71.53%-808.66M | -65.58%-312.43M | -45.79%-471.45M | -76.67%-188.69M | -36.20%-323.38M | 0.19%-106.8M | -16.65%-237.43M |
| Impairment and provision | 134.21%1.47M | -252.13%-481.15M | -32.24%-4.28M | 61.54%-136.64M | -506.78%-3.24M | -1,410.26%-355.29M | 111.94%796K | -1,391.76%-23.53M | ---6.67M | -2,326.15%-1.58M |
| -Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | -210.76%-11.15M | ---- | ---3.59M | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | -40,865.88%-208.93M | ---- | ---510K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | -30.18%-141.02M | ---- | ---108.32M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 134.21%1.47M | -371.88%-131.21M | -32.24%-4.28M | 91.92%-27.81M | -506.78%-3.24M | -1,626.13%-344.14M | 111.94%796K | -1,164.24%-19.94M | ---6.67M | -2,326.15%-1.58M |
| Operating interest expense | ---- | ---- | ---- | ---- | -161.64%-15.38M | -2.55%-17.83M | 37.09%-5.88M | -2.65%-17.39M | -25.48%-9.34M | -120.00%-16.94M |
| Special items of operating profit | 352.19%59.04M | 27.33%82.79M | -23.74%13.06M | -43.32%65.02M | -49.31%17.12M | -8.66%114.72M | -14.59%33.77M | 170.38%125.59M | 40.80%39.54M | -24.24%46.45M |
| Operating profit | -3.40%622.84M | 31.51%533.98M | 128.03%644.75M | 117.22%406.02M | 24.88%282.75M | -51.22%186.92M | 45.34%226.43M | -28.59%383.22M | -38.24%155.79M | -8.55%536.65M |
| Financing cost | 34.85%-39.84M | -85.30%-131.84M | ---61.15M | ---71.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | 6.74%44.33M | -1.63%90.78M | 17.23%41.53M | 12.49%92.29M | -17.77%35.43M | 142.02%82.04M | 861,780.00%43.08M | 23,438.89%33.9M | -400.00%-5K | 166.67%144K |
| Share of profit from joint venture company | ---- | ---- | ---- | -377.62%-4.22M | -769.37%-4.22M | 41.70%1.52M | 54.03%630K | -76.19%1.07M | -76.12%409K | 115.10%4.5M |
| Earning before tax | 0.35%627.33M | 16.55%492.92M | 99.11%625.13M | 56.37%422.94M | 16.22%313.96M | -35.32%270.48M | 72.96%270.14M | -22.74%418.19M | -38.49%156.19M | -8.09%541.3M |
| Tax | 16.34%-115.67M | -74.34%-165.03M | -218.82%-138.26M | -160.92%-94.66M | 33.10%-43.37M | 258.78%155.39M | -41.00%-64.82M | 30.43%-97.86M | 29.73%-45.97M | 5.84%-140.67M |
| After-tax profit from continuing operations | 5.09%511.66M | -0.12%327.89M | 79.92%486.87M | -22.91%328.28M | 31.79%270.6M | 32.95%425.86M | 86.29%205.33M | -20.05%320.32M | -41.54%110.22M | -8.85%400.63M |
| Earning after tax | 5.09%511.66M | -0.12%327.89M | 79.92%486.87M | -22.91%328.28M | 31.79%270.6M | 32.95%425.86M | 86.29%205.33M | -20.05%320.32M | -41.54%110.22M | -8.85%400.63M |
| Minority profit | -12.88%77.71M | 12.47%70.21M | 244.01%89.19M | 685.33%62.43M | 331.40%25.93M | -21.99%7.95M | 143.62%6.01M | 4.31%10.19M | -54.34%2.47M | 12.83%9.77M |
| Profit attributable to shareholders | 9.12%433.95M | -3.07%257.68M | 62.54%397.68M | -36.39%265.86M | 22.75%244.67M | 34.75%417.92M | 84.97%199.32M | -20.66%310.13M | -41.16%107.75M | -9.29%390.87M |
| Basic earnings per share | 9.68%0.34 | -4.76%0.2 | 63.16%0.31 | -36.36%0.21 | 18.75%0.19 | 32.00%0.33 | 77.78%0.16 | -19.35%0.25 | -40.00%0.09 | -8.82%0.31 |
| Diluted earnings per share | 9.68%0.34 | -4.76%0.2 | 63.16%0.31 | -36.36%0.21 | 18.75%0.19 | 32.00%0.33 | 77.78%0.16 | -19.35%0.25 | -40.00%0.09 | -8.82%0.31 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data